Related Experiment Video
Updated: Sep 23, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making
Elissa R Weitzman1,2,3, Joe Kossowsky3,4, Laura M Blakemore1
1Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Background:
The opioid epidemic worsened during the coronavirus disease 2019 (COVID-19) pandemic. Synthetic opioids (primarily fentanyl) comprise the most common drugs involved in overdose (OD) death. A vaccine that blocks fentanyl from reaching the brain to prevent OD is under development, and insight is needed into its acceptability.
Methods:
Using a semi-structured interview guide, persons with opioid use disorder (OUD), family, professionals, and the public were interviewed about attitudes and concerns regarding a fentanyl vaccine. Reactions to fictional clinical vignettes of persons at risk of OUD because of pain and/or substance use histories were collected, analyzed, and quantified for favorability. Interviews were transcribed, coded, and analyzed thematically.
Results:
Among N = 64 participants, (70.3% female, average age 32.4 years), attitudes were favorable toward a fentanyl vaccine, with preference for lifelong durability (76% of n = 55 asked). Perceived benefits centered on the potential for a life-saving intervention, suffering averted, healthcare dollars saved, and the utility of a passive harm reduction strategy. Concerns centered on uncertainty regarding vaccine safety, questions about efficacy, worry about implications for future pain management, stigma, and need for supportive counseling and guidance to personalize decision making. Reactions to vignettes revealed complex attitudes toward fentanyl vaccination when considering recipient age, health history, and future risks for addiction and pain.
Conclusions:
Positive responses to a fentanyl vaccine were found along with appreciation for the complexity of a vaccine strategy to prevent OD in the setting of pain and uncertain durability. Further research is needed to elucidate operational, ethical, and communications strategies to advance the model.
Insights
A new fentanyl vaccine shows promise for preventing overdose deaths, with most participants favoring its development. Concerns about safety and efficacy were noted, highlighting the need for further research into its implementation.
Area of Science:
- Pharmacology
- Public Health
- Vaccinology
Background:
- The opioid epidemic has been exacerbated by the COVID-19 pandemic, with synthetic opioids like fentanyl being primary drivers of overdose fatalities.
- A novel vaccine designed to prevent fentanyl overdose by blocking its access to the brain is currently under development.
- Understanding public and stakeholder attitudes towards this vaccine is crucial for its successful implementation.
Purpose of the Study:
- To assess the acceptability and identify concerns regarding a potential fentanyl vaccine among diverse populations.
- To explore attitudes towards a fentanyl vaccine in the context of opioid use disorder (OUD) and pain management.
Main Methods:
- Semi-structured interviews were conducted with individuals with OUD, their families, healthcare professionals, and the general public.
- Fictional clinical vignettes were used to gauge reactions to fentanyl vaccination scenarios.
- Interview data were transcribed, coded, and thematically analyzed, with vignette responses quantified for favorability.
Main Results:
- A majority of participants (70.3% female, average age 32.4 years) expressed favorable attitudes toward the fentanyl vaccine, with a strong preference for lifelong durability.
- Key perceived benefits included life-saving potential, reduced suffering, healthcare cost savings, and harm reduction.
- Primary concerns involved vaccine safety, efficacy, potential impact on future pain management, stigma, and the need for personalized counseling.
Conclusions:
- The study indicates positive reception for a fentanyl vaccine, alongside an acknowledgment of the complexities surrounding its use, particularly regarding durability and integration into pain management.
- Further research is essential to address operational, ethical, and communication strategies for advancing this harm reduction approach.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Parenteral Anesthetics: Overview
Dose-Response Relationship: Potency and Efficacy

